David DiLillo

Person

New York, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Chimeric antigen receptors with BCMA specificity and uses thereof
- Patent number 12,150,959
- Issue date Nov 26, 2024
- REGENERON PHARMACEUTICALS, INC.
- David DiLillo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof
- Patent number 11,905,332
- Issue date Feb 20, 2024
- REGENERON PHARMACEUTICALS, INC.
- David DiLillo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for treating cancer
- Patent number 11,826,386
- Issue date Nov 28, 2023
- REGENERON PHARMACEUTICALS, INC.
- David DiLillo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof
- Patent number 11,384,153
- Issue date Jul 12, 2022
- Regeneran Pharmaceuticals, Inc.
- Eric Smith
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Chimeric Antigen Receptors with BCMA Specificity and Uses Thereof
- Publication number 20240325445
- Publication date Oct 3, 2024
- Regeneron Pharmaceuticals, Inc.
- David DiLillo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chimeric Antigen Receptors with MAGE-A4 Specificity and Uses Thereof
- Publication number 20240226163
- Publication date Jul 11, 2024
- Regeneron Pharmaceuticals, Inc.
- Kevin BRAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING CANCER
- Publication number 20240165157
- Publication date May 23, 2024
- Regeneron Pharmaceuticals, Inc.
- David DiLillo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF
- Publication number 20240158529
- Publication date May 16, 2024
- Regeneron Pharmaceuticals, Inc.
- David DiLillo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING CANCER WITH A COMBINATION OF ADOPTIVE CELL THER...
- Publication number 20240148867
- Publication date May 9, 2024
- Regeneron Pharmaceuticals, Inc.
- David DiLillo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND CD38 AND 4-1BB, A...
- Publication number 20230416396
- Publication date Dec 28, 2023
- Regeneron Pharmaceuticals, Inc.
- Robert Babb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof
- Publication number 20220306758
- Publication date Sep 29, 2022
- Regeneron Pharmaceuticals, Inc.
- Eric Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chimeric Antigen Receptors with MAGE-A4 Specificity and Uses Thereof
- Publication number 20220281994
- Publication date Sep 8, 2022
- Regeneron Pharmaceuticals, Inc.
- Kevin Bray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 (NY-ESO-1) ANTIG...
- Publication number 20220251215
- Publication date Aug 11, 2022
- Regeneron Pharmaceuticals, Inc.
- Kevin A. Bray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF
- Publication number 20220089766
- Publication date Mar 24, 2022
- Regeneron Pharmaceuticals, Inc.
- David DiLillo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING CANCER
- Publication number 20220031748
- Publication date Feb 3, 2022
- Regeneron Pharmaceuticals, Inc.
- David DiLillo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof
- Publication number 20200024356
- Publication date Jan 23, 2020
- Regeneron Pharmaceuticals, Inc.
- Eric Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chimeric Antigen Receptors with BCMA Specificity and Uses Thereof
- Publication number 20200023010
- Publication date Jan 23, 2020
- Regeneron Pharmaceuticals, Inc.
- David DiLillo
- C07 - ORGANIC CHEMISTRY

David DiLillo

Person

Patents Grantslast 30 patents

Chimeric antigen receptors with BCMA specificity and uses thereof

Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof

Compositions and methods for treating cancer

Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof

Patents Applicationslast 30 patents

Chimeric Antigen Receptors with BCMA Specificity and Uses Thereof

Chimeric Antigen Receptors with MAGE-A4 Specificity and Uses Thereof

COMPOSITIONS AND METHODS FOR TREATING CANCER

ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF

METHODS OF TREATING CANCER WITH A COMBINATION OF ADOPTIVE CELL THER...

MULTISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND CD38 AND 4-1BB, A...

Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof

Chimeric Antigen Receptors with MAGE-A4 Specificity and Uses Thereof

ANTI-NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 (NY-ESO-1) ANTIG...

ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING CANCER

Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof

Chimeric Antigen Receptors with BCMA Specificity and Uses Thereof